Richard John Pearce

Renaissance Technologies LLC (Renaissance) is a SEC-registered investment advisor and global hedge fund manager headquartered in New York City. The firm was founded in 1982 and is a wholly owned subsidiary of Renaissance Technologies Holdings Corp. Renaissance acts as general partner, managing member, and/or investment manager to US and non-US private investment funds and an institutional account that invests in a variety of securities, futures, and derivatives contracts.

Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals.

Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets.

FIL Investment Advisors (UK) Ltd. (FIA UK) is a Great Britain-based fund management firm headquartered in Tadworth, Surrey. Founded in 1984, the firm is a wholly-owned subsidiary of FIL Holdings (UK) Limited, which in turn is a wholly-owned subsidiary of FIL Ltd. in Bermuda. FIA UK provides a range of global investment products and services to institutional accounts, mutual funds and other pooled investment vehicles.

Skagen AS (Investment Management) (Skagen-IM) is the investment management division of Skagen AS, itself a subsidiary of Storebrand ASA (OSE: STB, FRA: SKT) in Norway. The firm was founded in 1993 by Kristoffer Stensrud, Tor Dagfinn Veen and Åge Westbø. Headquartered in Stavanger, Skagen-IM manages Skagen global equity and fixed income funds for individual and institutional investors. They are a socially responsible investor.

GMO UK Ltd. is an investment management headquartered in London, UK. The firm was founded in 2003 and is a subsidiary of Grantham, Mayo, Van Otterloo LLC in the US. GMO UK offers a range of investment products, including equity and fixed-income strategies across global developed and emerging markets, as well as absolute return strategies. Their clients include endowments, pension funds, public funds, foundations and cultural institutions.

Accounting Research & Analytics LLC, do-business-as Center for Financial Research & Analysis (CFRA), is an investment research firm headquartered in New York City. The firm was founded in 1994 and is a subsidiary of CFRA Research, Inc. CFRA provides independent and actionable research and analytics to their global subscribers to improve their investment and business decisions. The firm’s services also include forensic accounting research and analytics that identifies public companies with deteriorating earnings quality; and fundamental research and commentary focused on stocks, ETFs, mutual funds, sectors and industries.

Part of CFRA Research Inc., The Center For Financial Research & Analysis (UK) is a leader in financial intelligence solutions. The company is based in London, UK. The British company offers expert analysis and insights to help businesses and investors make smarter, faster decisions. CFRA's Legal Research provides non-correlated, alpha-focused legal insights, assessing risks and identifying potential mispricings related to major patent, litigation, crisis, and regulatory events. The company offers real-time insights on legal themes, cases, and regulatory events for event-driven investors.

SFM UK Management LLP (SFM UK) is the Great Britain-based alternative investment subsidiary of Soros Fund Management LLC in the US. Headquartered in London, SFM UK was founded in 2008 and manages assets of high net worth clients.

CapeView Capital LLP (CapeView Capital) is an independent alternative investment firm headquartered in London, UK. The firm was founded by Theo Phanos in 2011 as BBM 2011 LLP. CapeView Capital provides investment advisory services to CapeView Funds and separate managed accounts. Investors in the CapeView Funds include investment advisers, fund of fund managers, pension plans, endowments, foundations, trusts and high net worth individuals that are sophisticated and experienced investors.

Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom.

Ahren Innovation Capital LLP (Ahren) is a venture capital firm founded in 2017 by Alice Newcombe-Ellis. The firm is headquartered in Cambridge, UK.

Zoe Global Ltd. is nutritional science company. It helps people eat with confidence. The company was founded by Tim Spector, Jonathan Wolf and George Hadjigeorgiou and is headquartered in London, the United Kingdom.

Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom.